No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 2.820
- +0.220+8.46%
15min DelayMarket Closed Dec 20 16:00 ET
69.52MMarket Cap23.11P/E (TTM)
2.820High2.610Low5.85KVolume2.650Open2.600Pre Close15.55KTurnover3.27052wk High0.03%Turnover Ratio24.65MShares1.47052wk Low0.122EPS TTM62.82MFloat Cap11.250Historical HighLossP/E (Static)22.27MShs Float0.880Historical Low-0.014EPS LYR8.08%Amplitude--Dividend TTM1.48P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Stifel Nicolaus Keeps Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)
Medexus Pharmaceuticals Inc Raised to Outperform From Market Perform by Raymond James
Medexus and Pan-Canadian Pharmaceutical Alliance (PCPA) Successfully Complete Negotiations for Trecondyv (Treosulfan for Injection) in Canada
Should We Be Cautious About Medexus Pharmaceuticals Inc.'s (TSE:MDP) ROE Of 7.0%?
Medexus Pharmaceuticals Inc. (MEDXF) Q2 2025 Earnings Call Transcript Summary
Medexus Pharmaceuticals Inc: INTERIM MDA EN
Heat List
CA
Overall
Symbol
Price
% Chg
No Data